The Life Sciences sector is characterized by continuous scientific, technological, and regulatory evolution. From research through to market authorization and commercialization, each stage presents specific risks that require specialized expertise.
DBDG supports biotechnology startups, pharmaceutical companies, medical device manufacturers, CROs, universities, IRCCSs, and research centers, designing insurance programs tailored to the characteristics and activities of each organization.
CPHI Milan
6–8 ottobre 2026
Meet in Italy for Life Sciences
Roma, 13–14 ottobre 2026